Medicus Pharma Ltd. Warrant closed at $0.31 on Sep 23, down 12.68%, 71.8% below its highest close since Nov 14. Volume of 1.4K shares was 1.21× its 20-day average (close to normal).
Split-adjusted performance: -44.7% over six months.
Short interest was 27.7K shares at the Sep 15 settlement, down 6.6% from the prior report (34.9 days to cover).
No reported quarters with price history yet.
Percentile among 423 companies (100 = best)
Industry medians: 6-month return −2.9%, revenue growth +6.4%, net margin −41.2%, P/E 16.2×.
| Company | Price | Today | 6M | Rev. growth | Net margin | P/E | Mkt cap | |
|---|---|---|---|---|---|---|---|---|
| MDCXWMedicus Pharma Ltd. Warrant | $0.3100 | −12.68% | −44.7% | — | — | — | $305.5K | |
| BFRGWBullfrog AI Holdings, Inc. Warrants | $0.1535 | −19.21% | −9.7% | +547.6% | −636.8% | — | $202.3K | Compare |
| SBFMWSunshine Biopharma Inc. warrant | $0.0540 | +74.19% | −61.4% | −1.6% | −16.9% | — | $165.4K | Compare |
| BFRIWBiofrontera Inc. Warrants | $0.0135 | −32.50% | −66.5% | +32.9% | −5.0% | — | $20.1K | Compare |
| NAMSWNewAmsterdam Pharma Company N.V. Warrant | $11.40 | −0.78% | — | −80.7% | −1732.9% | — | $52.4M | Compare |
| ASBPWAspire-Lakewood Holdings, Inc. Warrant | $0.0133 | −32.83% | −9.5% | — | −2009.6% | — | $159.32 | Compare |
Medicus Pharma Ltd is a clinical-stage, life sciences, biotech company focused on investing in and accelerating clinical development programs of novel and potentially disruptive therapeutic assets. The company has one operating segment.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
